PDC*line Pharma Employee Directory
Biotechnology ResearchWallonia, Belgium2-10 Employees
PDC*line Pharma develops a class of off-the-shelf therapeutic cancer vaccines based on a proprietary line of Plasmacytoid Dendritic Cells, referred to as PDC*line. These vaccines aim to stimulate the immune system to attack tumors, offering a scalable alternative to personalized approaches. The company has progressed its programs through early clinical testing, including a first-in-human Phase Ib in melanoma and Phase I/II results in lung cancer for PDC*lung. Current development plans include a randomized Phase II trial in lung cancer and a Phase Ib trial in colorectal cancer using neoantigens (PDC*neo). PDC*line Pharma is based in Liège, in the Wallonia region of Belgium, and operates within the biotechnology research sector focused on cancer immunotherapies.
1-888-653-2347 
support@leadiq.com 
